Ken Anderson

Chief, Division of Hematologic Neoplasia at Dana-Farber Cancer Institute, Inc.

Ken Anderson

Ken Anderson

Chief, Division of Hematologic Neoplasia at Dana-Farber Cancer Institute, Inc.

Overview
Career Highlights

American Society of Hematology
C4 Therapeutics, Inc.
Acetylon Pharmaceuticals, Inc.

RelSci Relationships

4149

Number of Boards

15

Birthday

1952

Age

69

Relationships
RelSci Relationships are individuals Ken Anderson likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at C4 Therapeutics, Inc.

Relationship likelihood: Strong

President at Novartis Institutes for BioMedical Research, Inc.

Relationship likelihood: Strong

Advisory Partner at NewSpring Healthcare

Relationship likelihood: Strong

Co-Founder at The Multiple Myeloma Research Foundation, Inc.

Relationship likelihood: Strong

Pediatric Hematology/Oncology at Dana-Farber Cancer Institute, Inc.

Relationship likelihood: Strong

Managing Director at Metropolitan Opera Association, Inc.

Relationship likelihood: Strong

Founder at EG Capital Group LLC

Relationship likelihood: Strong

Co-Founder at Frequency Therapeutics, Inc.

Relationship likelihood: Strong

Director, Center for Cancer Genetics & Prevention at Dana-Farber Cancer Institute, Inc.

Relationship likelihood: Strong

Interim Executive Vice President & Chief Operating Officer & Chief Scientific Officer at Dana-Farber Cancer Institute, Inc.

Relationship likelihood: Strong

Paths to Ken Anderson
Potential Connections via
Relationship Science
You
Ken Anderson
Chief, Division of Hematologic Neoplasia at Dana-Farber Cancer Institute, Inc.
Education
Masters in Art
Class of 2000

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

MD
Class of 1977

The Johns Hopkins University School of Medicine (JHUSOM), located in Baltimore, Maryland, U.S., is the academic medical teaching and research arm of Johns Hopkins University. Johns Hopkins has consistently been among the nation's top medical schools in the number of research grants awarded by the National Institutes of Health.

Bachelor's Degree, summa cum laude
Class of 1973

Boston University (most commonly referred to as BU) is a private research university located in Boston, Massachusetts. The university is nonsectarian, but is historically affiliated with the United Methodist Church. The university has more than 4,000 faculty members and 29,000 students,and is one of Boston's largest employers. It offers bachelor's degrees, master's degrees, and doctoral degrees, and medical and dental degrees through 18 schools and colleges on two urban campuses. The main campus is situated along the Charles River in Boston's Fenway-Kenmore and Allston neighborhoods, while the Boston University Medical Campus is in Boston's South End neighborhood. BU also operates 75 study abroad programs in over 33 cities in over 20 countries and has internship opportunities in 10 different countries (including the United States and abroad).

Career History
Professor
2002 - Current

Harvard Medical School (HMS) is the graduate medical school of Harvard University. It is located in the Longwood Medical Area of the Mission Hill neighborhood of Boston, Massachusetts.The school was founded by John Warren on September 19, 1782, with Benjamin Waterhouse, and Aaron Dexter.

Co-Founder
Current

C4 Therapeutics, Inc. provides new class of targeted protein degradation. It develops Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by James E. Bradner, Kenneth C. Anderson, Nathanael S. Gray and Marc A. Cohen in October 2015 and is headquartered in Cambridge, MA.

Chief, Division of Hematologic Neoplasia
Current

Since its founding in 1947, Dana-Farber has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research. Read about our history, our breakthroughs, and the resources that help us support the health of our neighborhoods and communities.

Boards & Committees
Member, Scientific Advisory Board
Current
Director
Prior

Gentium Srl manufactures and develops biopharmaceutical products. It offers discovery, research, development and manufacture of drugs for the treatment and prevention of a variety of vascular diseases and conditions related to cancer and cancer treatments. The company was founded by Laura Iris Ferro and is headquartered in Villa Guardia, Italy.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$500 - $999
2003

International Myeloma Foundation is an American nonprofit company located in North Hollywood, CA, that supports myeloma patients.The company says this about itself: Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest foundation focusing specifically on multiple myeloma. The Foundation's reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure by focusing on four key areas: research, education, support, and advocacy.

Investments
Details Hidden

C4 Therapeutics, Inc. provides new class of targeted protein degradation. It develops Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system. The company was founded by James E. Bradner, Kenneth C. Anderson, Nathanael S. Gray and Marc A. Cohen in October 2015 and is headquartered in Cambridge, MA.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ken Anderson. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ken Anderson's profile does not indicate a business or promotional relationship of any kind between RelSci and Ken Anderson.